Kinome analysis of Madurella mycetomatis identified kinases in the cell wall integrity pathway as novel potential therapeutic drug targets in eumycetoma caused by Madurella mycetomatis. [PDF]
Eumycetoma is a neglected tropical subcutaneous disease most commonly caused by the fungus Madurella mycetomatis. Currently, eumycetoma is treated by a combination of antifungal therapy and surgery, with limited success rates.
Mickey Konings +16 more
doaj +2 more sources
Madurella mycetomatis-Induced Massive Shoulder Joint Destruction: A Management Challenge. [PDF]
Peter S Scolding +3 more
doaj +5 more sources
Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim. [PDF]
OBJECTIVES: Eumycetoma is currently treated with a combination of itraconazole therapy and surgery, with limited success. Recently, olorofim, the lead candidate of the orotomides, a novel class of antifungal agents, entered a Phase II trial for the ...
Lim W +8 more
europepmc +3 more sources
Th-1, Th-2 Cytokines Profile among Madurella mycetomatis Eumycetoma Patients. [PDF]
Eumycetoma is a progressive and destructive chronic granulomatous subcutaneous inflammatory disease caused by certain fungi, the most common being Madurella mycetomatis.
Amre Nasr +4 more
doaj +4 more sources
Madurella mycetomatis infection following allogenic stem cell transplantation for aplastic anemia
Madurella mycetomatis is the most common fungal agent causing eumycetoma. The commonest clinical presentation of the infection is the appearance of multiple sinuses with discharge of grains, which are the colonies of the fungus.
Sanjeev Kumar Sharma +9 more
doaj +4 more sources
Environmental detection of eumycetoma pathogens using multiplex real-time PCR for soil DNA in Sennar State, Sudan [PDF]
Background Mycetoma is a chronic disease affecting the skin and subcutaneous tissue endemic in the tropical and subtropical regions. Several bacteria and fungi can cause mycetoma, but fungal mycetoma (eumycetoma) is challenging because the treatment ...
Hiroki Hashizume +7 more
doaj +4 more sources
Identification of Microbial-Based Natural Products as Potential CYP51 Inhibitors for Eumycetoma Treatment: Insights from Molecular Docking, MM-GBSA Calculations, ADMET Analysis, and Molecular Dynamics Simulations [PDF]
Background/Objectives: Eumycetoma, caused by Madurella mycetomatis, is a chronic fungal infection with limited treatment options and increasing drug resistance.
Tilal Elsaman +4 more
doaj +2 more sources
Eumycetoma by Madurella mycetomatis with 30 years of evolution: therapeutic challenge [PDF]
We report a case of eumycetoma by Madurella mycetomatis on the buttocks and thighs in an adult immunocompetent patient, diagnosed after 30 years of clinical development.
Felipe Maurício Soeiro Sampaio +5 more
doaj +5 more sources
Sandalwood Sesquiterpene (Z)-α-Santalol Exhibits In Vivo Efficacy Against Madurella mycetomatis in Galleria mellonella Larvae [PDF]
In continuation of our recent report on the in vitro activity of sandalwood essential oils and their major components, the sesquiterpenes (Z)-α- and -β-santalols, against the pathogenic fungus Madurella mycetomatis, causative agent of the neglected ...
Shereen O. Abd Algaffar +6 more
doaj +2 more sources
Madurella mycetomatis infection of the buttock in an Eritrean refugee in Switzerland: a case report [PDF]
Background Mycetoma is a neglected infectious disease caused by a fungus (eumycetoma) or bacteria (actinomycetoma); it is characterized by chronic local inflammation with sinus formation and purulent discharge. Its course can be quite devastating because
Carine Mekoguem +2 more
doaj +2 more sources

